ACCEPTING APPLICATIONS

 

2020 International Research Grant Program

Learn more information from our complete International Research Grant Program Announcement January 2020 Program (August 2019 – February 2020).

   Download

Competition objectives

The Alzheimer’s Association Research Grant to Promote Diversity - New to the Field award is up to three years (minimum two years) to increase the number of scientists from underrepresented groups at academic institutions in Alzheimer’s and all dementia research.

The AARG-D-NTF aims to fund individuals who are new to the Alzheimer’s and all dementia field of research. Individuals who are new to the field of neuroscience or neurodegeneration (Alzheimer’s, Parkinson’s, Lewy body dementia, etc.) will be considered for this program.

Individuals who are new to the field of neuroscience/Alzheimer’s will need to contact the Association at grantsapp@alz.org to receive an exception prior to submitting an LOI. Individuals who are new to the field of neuroscience or neurodegeneration (Alzheimer’s, Parkinson’s, Lewy body dementia, etc.) will be considered.

The goal of the New to the Field program is to provide an opportunity for investigators with expertise outside neurodegenerative research to apply their expertise to advance and accelerate Alzheimer’s disease and all dementia research. Competitive applications to this program emphasize how the specific expertise/approach will advance research.

The objective of this award is to increase the number of highly trained investigators from diverse backgrounds whose basic, clinical and social/behavioral research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to Alzheimer’s and all dementias in general and in health disparities populations.

The Alzheimer’s Association recognizes the need to increase the number of scientists from underrepresented groups participating in biomedical and behavioral research. The Association anticipates that, by providing these research opportunities, the number of scientists from underrepresented groups entering and remaining in biomedical research careers in Alzheimer’s disease and all dementias will increase.

Funding and award period

Each AARG-D-NTF award is limited to $150,000 (direct and indirect costs) for up to three years (minimum two years). Requests in any given year may not exceed $60,000 (direct and indirect costs). Indirect costs are capped at 10 percent (rent for laboratory/office space is expected to be covered by indirect costs paid to the institution).

Eligibility

Applicants must be Assistant Professors or above at their respective institution. For individuals who are at non-academic institutions, please contact the Alzheimer’s Association at grantsapp@alz.org to verify your eligibility.

Eligibility to apply for this grant competition is restricted to investigators who are new to the Alzheimer’s and all dementia field of research. Individuals who are new to the field as defined above will need to contact the Association at grantsapp@alz.org to receive an exception prior to submitting an LOI. If you submit an LOI without an approved exception, your LOI will be rejected.

Specific for the AARG-D-NTF program, eligible applicants are faculty members who have been determined to be from underrepresented groups in biomedical and behavioral research on a national or institutional basis. The Alzheimer’s Association will require documentation to support the faculty member’s underrepresented status at their institution. Applicants in the United States will be subject to the definitions as stated by the National Institutes of Health:

  1. Individuals from racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented in health-related sciences on a national basis. The following racial and ethnic groups have been shown to be underrepresented in biomedical research: African Americans, Hispanic Americans, American Indians, Alaska Natives, Native Hawaiians, and other Pacific Islanders. In addition, it is recognized that underrepresentation can vary from setting to setting; individuals from racial or ethnic groups that can be convincingly demonstrated to be underrepresented by the grantee institution should be encouraged to participate in this program.
  2. Individuals with disabilities, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities. 
  3. Individuals from disadvantaged backgrounds who are defined as: 
  • Individuals who come from a family with an annual income below established low-income thresholds. These thresholds are based on family size; published by the U.S. Bureau of the Census; adjusted annually for changes in the Consumer Price Index; and adjusted by the Secretary for use in all health professions programs. The Secretary periodically publishes these income levels at HHS - Poverty Guidelines, Research, and Measurement. For individuals from low-income backgrounds, the institution must be able to demonstrate that such participants have qualified for Federal disadvantaged assistance or they have received any of the following student loans: Health Professions Student Loans (HPSL), Loans for Disadvantaged Student Program, or they have received scholarships from the U.S. Department of Health and Human Services under the Scholarship for Individuals with Exceptional Financial Need.
  • Individuals who come from a social, cultural, or educational environment such as that found in certain rural or inner-city environments that have demonstrably and recently directly inhibited the individual from obtaining the knowledge, skills, and abilities necessary to develop and participate in a research career. 

Applicants must submit a Letter of Assurance printed on the hiring institution's letterhead, signed by an authorized institutional official (i.e., Grants and Contracts officer) that states you have been determined by your institution to be underrepresented in the above areas at the time of Letter of Intent (LOI) for verification. The Alzheimer’s Association reserves the right to require additional documentation to help confirm the applicant’s eligibility. Non-U.S. applicants in addition to the letter must provide official documentation from their institutional materials, such as website, manual or other legal documentation, that indicates their eligibility for this program.

Please note: If the applicant's institution does not have an Assistant Professor position, the letter of employment should include sufficient information to allow the Alzheimer’s Association staff to evaluate the eligibility of the applicant.

Ineligibility

The Alzheimer's Association will not accept new grant applications from currently funded investigators who are delinquent in submitting required reports and other deliverables on active grants. Investigators who have previous Alzheimer’s Association awards closed as "Incomplete" are not eligible to apply without exception. This policy will be strictly adhered to with no exceptions.

Deadlines and award dates

Letters of Intent must be received by 5 p.m. EST, September 30, 2019. Letters of Intent will not be accepted after this date. No exceptions will be made. Hard copies or emails will not be accepted.

New requirement: All applicants must include an ORCID ID. It is a required field. You will not be able to submit your LOI without this information.

Applications must be received by 5 p.m. EST, November 20, 2019.

Scientific and technical review will be conducted from November 2019 – January 2020. The Alzheimer’s Association will lead a second-tier review with leading research experts to evaluate each program during January 2020. Funding will be awarded by February 15, 2020.

LOI review procedures: (Note: Feedback is not provided at the LOI stage for LOIs not invited to submit a full application.)

All LOIs will be evaluated prior to invitation. Only LOIs that meet program specific guidelines will be invited to submit full applications. LOIs will also be reviewed by the Alzheimer’s Association panel of experts with special attention to:

  1. Background and training of applicant and how transitioning to the field will elevate Alzheimer’s and all dementia research; specifically, how their unique expertise applied to Alzheimer’s and all dementias will advance/elevate research in potentially new directions
  2. Demonstrable innovation/novelty of the proposed project (especially in the context of the PIs recently funded work)
  3. Alignment with the research priorities of the Alzheimer's Association
  4. Impact of project on Alzheimer's disease and all dementia research
  5. Evidence of methodological rigor that addresses the research question(s) being proposed

Applications will be reviewed with special attention to: 

  • Significance of the question being studied
  • Applicant information – including the training of the PI insofar as it enables them to perform the work proposed and qualifications of the collaborators and the expertise they bring to the project. Special consideration will be given to description of how transitioning to the field will elevate Alzheimer's and all dementia research
  • Quality of the work plan, including novelty and innovation of the proposed project
  • Quality and adequacy of available resources and budget
  • Impact-risk of the proposal and how it will add to the field’s overall knowledge and advancement
Please note: Resubmissions will have the opportunity to provide a response to prior review.
 

Mechanism of award, reporting requirements and allowable costs

The mechanism of the award is the individual research grant. The maximum allowable duration is three years (minimum two years). Annual scientific progress and financial reports are required. Continuation of the grant over the awarded duration is contingent upon the timely receipt of scientific progress and financial reports.

Budget

A “budget summary” for the proposed research project is required and must be submitted with the application and within the allowable two-page limit. However, if the application is to be awarded, a more detailed budget will be required and must be approved before the disbursement of funds. Your budget must not exceed the maximum amount of the award, $150,000 or $60,000 per year for up to three years (minimum two years – award cannot be for only one year).

Please note: If you only request the award for two years, the max amount you can request is $120,000 or $60,000 per year. 

Allowable costs under this award 

It is required that most of the funds awarded under this program be used for direct research support. No more than 10 percent of the total award may be included as indirect costs.

Allowable costs under this award include: 

  • Purchase and care of laboratory animals
  • Small pieces of laboratory equipment and laboratory supplies (purchases over $10,000 require prior approval, even if included in the project proposal budget)
  • Computer equipment if used strictly for data collection (requires prior approval)
  • Support for travel to scientific and professional meetings not to exceed $3,000 per year; additional support for travel expenses necessary to carry our research planned not to exceed $1,000 per year – this may include site visits. Total travel cost should not exceed $5,000 for the duration of the award.
  • Salary for the principal investigator, scientific (including postdoctoral fellows) and technical staff (including laboratory technicians and administrative support related directly to the funded project)

Direct costs not allowed under this award include: 

  • Tuition
  • Computer hardware or software for investigators
  • Rent for laboratory/office space
  • Construction or renovation costs
  • Salary and/or compensation for Alzheimer’s Association staff or members of the Alzheimer’s Association Medical and Scientific Advisory Group (MSAG) and the International Research Grant Program (IRGP) Council

For more information: Contact grantsapp@alz.org

Other grants we fund